← Back
$LXRX All transactions

LEXICON PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

103,806

Price

$0

Filed

Jun 3

Insider

Name

DEBBANE RAYMOND

Title

CIK

0001053890

Roles

Director

Transaction Details

Transaction Date

2025-06-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

103,806

Footnotes

Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. | Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. | Each restricted stock unit represents a contingent right to receive one share of common stock.

Filing Info

Accession No.

0001127602-25-016458

Form Type

4

Issuer CIK

0001062822

DEBBANE RAYMOND's History

Date Ticker Type Value
2026-02-25 LXRX $3K
2026-02-23 LXRX $147K
2026-02-20 LXRX $148K
2026-02-19 LXRX $72K
2026-02-18 LXRX $176K
2026-02-17 LXRX $101K
2026-02-13 LXRX $76K
2025-06-03 LXRX A $0
2025-06-03 LXRX A $0
2025-05-13 LXRX M $0

Other Insiders at LXRX (90d)

Insider Bought Sold Last
Invus Global Management, LLC $2.0M 2026-02-02
DEBBANE RAYMOND $723K 2026-02-25
Coiante Scott M
SVP, Chief Financial Officer
2026-02-28
Crum Brian T
SVP, General Counsel & Secr.
2026-02-28
DeFrancesco Lisa
SVP, IR and Corp Comm
2026-02-28
Granowitz Craig B
SVP, Chief Medical Officer
2026-02-28
McDermott Wendy
SVP, Human Resources
2026-02-28
Exton Michael
Chief Executive Officer
2026-02-28
Artal Participations S.a r.l. 2026-02-17
Gopinathan Suma
SVP, Discovery
2026-02-28
Martens Rachel Yap
SVP, Partnerships & Corp Strat
2026-02-28